| glycine transport | GO:0015816 | 4 | 0.474 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.417 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.343 | |
| synaptic transmission | GO:0007268 | 329 | 0.295 | |
| dopamine catabolic process | GO:0042420 | 4 | 0.295 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.272 | |
| locomotory behavior | GO:0007626 | 195 | 0.272 | |
| monoamine transport | GO:0015844 | 33 | 0.270 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.258 | |
| regulation of neurotransmitter transport | GO:0051588 | 35 | 0.253 | |
| l alpha amino acid transmembrane transport | GO:1902475 | 23 | 0.244 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.237 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.233 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.213 | Rat |
| regulation of neuron projection development | GO:0010975 | 169 | 0.208 | |
| amine metabolic process | GO:0009308 | 45 | 0.206 | Rat |
| erythrocyte differentiation | GO:0030218 | 88 | 0.205 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.183 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.179 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.178 | |
| transmembrane transport | GO:0055085 | 412 | 0.174 | |
| regulation of ion transport | GO:0043269 | 215 | 0.164 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.148 | |
| organic anion transport | GO:0015711 | 137 | 0.146 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.145 | |
| vesicle localization | GO:0051648 | 86 | 0.142 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.140 | Human |
| glial cell differentiation | GO:0010001 | 131 | 0.136 | |
| neutral amino acid transport | GO:0015804 | 13 | 0.132 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.127 | |
| anion transport | GO:0006820 | 177 | 0.125 | |
| action potential | GO:0001508 | 78 | 0.120 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.120 | Rat |
| cellular amine metabolic process | GO:0044106 | 44 | 0.119 | Rat |
| regulation of membrane potential | GO:0042391 | 192 | 0.114 | |
| dopamine transport | GO:0015872 | 15 | 0.113 | |
| beta alanine transport | GO:0001762 | 1 | 0.112 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.110 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.109 | |
| response to inorganic substance | GO:0010035 | 96 | 0.108 | Human |
| regulation of cell projection organization | GO:0031344 | 206 | 0.102 | |
| amino acid transport | GO:0006865 | 61 | 0.100 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.100 | |
| protein polymerization | GO:0051258 | 57 | 0.099 | Human |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.098 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.097 | |
| l amino acid transport | GO:0015807 | 32 | 0.096 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.095 | |
| dopamine metabolic process | GO:0042417 | 23 | 0.095 | |
| sulfur compound transport | GO:0072348 | 9 | 0.093 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.092 | Human |
| response to organic cyclic compound | GO:0014070 | 198 | 0.090 | Rat |
| homeostasis of number of cells | GO:0048872 | 210 | 0.086 | |
| cation transport | GO:0006812 | 399 | 0.085 | |
| catecholamine transport | GO:0051937 | 21 | 0.084 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.084 | |
| membrane organization | GO:0061024 | 245 | 0.083 | |
| catecholamine catabolic process | GO:0042424 | 5 | 0.081 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.080 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.080 | Human |
| phenol containing compound catabolic process | GO:0019336 | 7 | 0.079 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.078 | |
| developmental maturation | GO:0021700 | 193 | 0.078 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.078 | |
| forebrain development | GO:0030900 | 302 | 0.075 | |
| regulation of mitochondrial fission | GO:0090140 | 3 | 0.071 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.071 | |
| neurotransmitter uptake | GO:0001504 | 14 | 0.071 | Human |
| regulation of secretion | GO:0051046 | 274 | 0.071 | |
| organelle localization | GO:0051640 | 179 | 0.070 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.069 | |
| learning or memory | GO:0007611 | 148 | 0.067 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.067 | |
| synaptic vesicle transport | GO:0048489 | 57 | 0.066 | |
| neuronal action potential | GO:0019228 | 54 | 0.066 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.066 | Human |
| organic acid transport | GO:0015849 | 101 | 0.065 | |
| cation homeostasis | GO:0055080 | 212 | 0.064 | Human |
| regulation of system process | GO:0044057 | 200 | 0.064 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.064 | Human |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.063 | Human |
| long term synaptic potentiation | GO:0060291 | 25 | 0.062 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.061 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.061 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.061 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.061 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.061 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.060 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.060 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.060 | |
| regulation of dopamine secretion | GO:0014059 | 9 | 0.059 | |
| synaptic transmission glutamatergic | GO:0035249 | 36 | 0.059 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.059 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.057 | |
| adult behavior | GO:0030534 | 135 | 0.057 | |
| catechol containing compound catabolic process | GO:0019614 | 5 | 0.057 | |
| cellular homeostasis | GO:0019725 | 240 | 0.056 | Human |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.056 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.056 | Human |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.056 | Rat |
| dendritic spine organization | GO:0097061 | 26 | 0.056 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.055 | Human |
| camera type eye development | GO:0043010 | 266 | 0.055 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.054 | |
| microtubule based process | GO:0007017 | 236 | 0.054 | Human |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.054 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.054 | Human |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.054 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.053 | Human |
| positive regulation of secretion | GO:0051047 | 130 | 0.053 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.053 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.052 | |
| gliogenesis | GO:0042063 | 141 | 0.052 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.052 | |
| regulation of catecholamine secretion | GO:0050433 | 12 | 0.051 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.051 | Human |
| synaptic vesicle priming | GO:0016082 | 8 | 0.050 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.050 | Human |
| cellular response to ammonium ion | GO:0071242 | 2 | 0.050 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.050 | |
| gland development | GO:0048732 | 330 | 0.050 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.049 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.048 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.048 | |
| pole plasm assembly | GO:0007315 | 2 | 0.047 | |
| membrane fusion | GO:0061025 | 38 | 0.047 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.047 | |
| oocyte axis specification | GO:0007309 | 2 | 0.047 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.046 | Human |
| cell adhesion | GO:0007155 | 329 | 0.046 | |
| detection of stimulus | GO:0051606 | 84 | 0.044 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.044 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.044 | Human |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.043 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.043 | Human |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.043 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.043 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.042 | |
| peptide secretion | GO:0002790 | 114 | 0.042 | |
| cell maturation | GO:0048469 | 127 | 0.042 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.042 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.041 | |
| chemotaxis | GO:0006935 | 247 | 0.041 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.041 | Human |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.041 | |
| protein ubiquitination | GO:0016567 | 171 | 0.041 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.041 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.041 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.040 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.040 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.040 | |
| metencephalon development | GO:0022037 | 89 | 0.040 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.039 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.039 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.039 | |
| endocytosis | GO:0006897 | 168 | 0.038 | |
| muscle system process | GO:0003012 | 141 | 0.038 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.038 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.038 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.038 | |
| fat cell differentiation | GO:0045444 | 160 | 0.038 | |
| cell growth | GO:0016049 | 130 | 0.037 | |
| dendritic spine development | GO:0060996 | 30 | 0.037 | |
| amide transport | GO:0042886 | 138 | 0.037 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.037 | Human |
| nucleotide metabolic process | GO:0009117 | 332 | 0.037 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.036 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.036 | Rat |
| neurotransmitter secretion | GO:0007269 | 62 | 0.036 | |
| heart process | GO:0003015 | 94 | 0.036 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.036 | |
| response to nicotine | GO:0035094 | 6 | 0.036 | |
| amine transport | GO:0015837 | 21 | 0.036 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.035 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.035 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.035 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.035 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.035 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.035 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.035 | |
| muscle contraction | GO:0006936 | 101 | 0.034 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.034 | Rat |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.034 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.034 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.034 | |
| pigment biosynthetic process | GO:0046148 | 26 | 0.034 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.034 | Human |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.034 | |
| axonogenesis | GO:0007409 | 274 | 0.033 | |
| cofactor biosynthetic process | GO:0051188 | 41 | 0.033 | |
| response to amine | GO:0014075 | 16 | 0.033 | |
| neuron death | GO:0070997 | 154 | 0.033 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.033 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.032 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.032 | |
| maintenance of location | GO:0051235 | 89 | 0.032 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.032 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.032 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.032 | |
| sensory perception | GO:0007600 | 245 | 0.032 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.032 | Human |
| catecholamine secretion | GO:0050432 | 15 | 0.032 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.031 | |
| endomembrane system organization | GO:0010256 | 147 | 0.031 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.031 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.031 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.031 | |
| renal sodium excretion | GO:0035812 | 3 | 0.031 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.031 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.030 | Human |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.030 | |
| dopamine receptor signaling pathway | GO:0007212 | 16 | 0.030 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.030 | Human |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.030 | |
| response to corticosterone | GO:0051412 | 1 | 0.030 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.030 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.030 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.030 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.029 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.029 | |
| telencephalon development | GO:0021537 | 186 | 0.029 | |
| response to metal ion | GO:0010038 | 47 | 0.029 | Human |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.029 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.029 | |
| protein catabolic process | GO:0030163 | 221 | 0.029 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.029 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.029 | Human |
| vasodilation | GO:0042311 | 28 | 0.028 | |
| angiogenesis | GO:0001525 | 201 | 0.028 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.028 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.028 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.028 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.028 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.028 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.028 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.028 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.027 | |
| negative regulation of action potential | GO:0045759 | 1 | 0.027 | |
| regulation of g protein coupled receptor protein signaling pathway | GO:0008277 | 37 | 0.027 | Human |
| second messenger mediated signaling | GO:0019932 | 73 | 0.027 | |
| dopamine biosynthetic process | GO:0042416 | 6 | 0.027 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.027 | |
| oocyte construction | GO:0007308 | 2 | 0.027 | |
| response to ammonium ion | GO:0060359 | 21 | 0.027 | Rat |
| response to radiation | GO:0009314 | 165 | 0.027 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.027 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.027 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.027 | |
| axon ensheathment | GO:0008366 | 76 | 0.026 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.026 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.026 | |
| response to drug | GO:0042493 | 75 | 0.026 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.025 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.025 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.025 | Human |
| neuron apoptotic process | GO:0051402 | 142 | 0.025 | |
| negative regulation of growth | GO:0045926 | 99 | 0.025 | |
| exploration behavior | GO:0035640 | 21 | 0.025 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.025 | |
| neural nucleus development | GO:0048857 | 22 | 0.025 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.025 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| circulatory system process | GO:0003013 | 197 | 0.024 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.024 | |
| regulation of defense response | GO:0031347 | 233 | 0.024 | |
| regulation of binding | GO:0051098 | 111 | 0.024 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.024 | |
| regulation of cell motility | GO:2000145 | 236 | 0.024 | |
| regulation of ph | GO:0006885 | 26 | 0.024 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.024 | |
| response to mineralocorticoid | GO:0051385 | 1 | 0.024 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.024 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.024 | |
| response to oxidative stress | GO:0006979 | 123 | 0.024 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.024 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.024 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.023 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.023 | Human Rat |
| intracellular protein transport | GO:0006886 | 204 | 0.023 | |
| protein localization to organelle | GO:0033365 | 185 | 0.023 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.023 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.023 | Rat |
| phenol containing compound biosynthetic process | GO:0046189 | 21 | 0.023 | |
| neuron projection guidance | GO:0097485 | 141 | 0.023 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.023 | |
| axon guidance | GO:0007411 | 141 | 0.023 | |
| synaptic vesicle fusion to presynaptic membrane | GO:0031629 | 3 | 0.023 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.023 | Human |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.022 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.022 | |
| response to cocaine | GO:0042220 | 14 | 0.022 | Rat |
| divalent metal ion transport | GO:0070838 | 172 | 0.022 | Human |
| dendrite development | GO:0016358 | 115 | 0.022 | |
| dopamine secretion | GO:0014046 | 9 | 0.022 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.022 | |
| synaptic vesicle docking involved in exocytosis | GO:0016081 | 4 | 0.022 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.022 | Human Rat |
| telencephalon cell migration | GO:0022029 | 55 | 0.022 | |
| cytokine production | GO:0001816 | 319 | 0.022 | |
| heart morphogenesis | GO:0003007 | 178 | 0.022 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.022 | |
| regulation of action potential | GO:0098900 | 4 | 0.022 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.022 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.022 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.022 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.022 | Human |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.021 | |
| intraspecies interaction between organisms | GO:0051703 | 21 | 0.021 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.021 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.021 | |
| dephosphorylation | GO:0016311 | 129 | 0.021 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.021 | |
| protein processing | GO:0016485 | 163 | 0.021 | Human |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.021 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.021 | |
| inflammatory response | GO:0006954 | 244 | 0.021 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.021 | |
| positive regulation of neurotransmitter transport | GO:0051590 | 9 | 0.021 | |
| retrograde transport endosome to golgi | GO:0042147 | 2 | 0.021 | |
| mitochondrial transport | GO:0006839 | 36 | 0.020 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.020 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.020 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.020 | |
| catecholamine uptake involved in synaptic transmission | GO:0051934 | 4 | 0.020 | Human |
| serotonin transport | GO:0006837 | 11 | 0.020 | Human |
| deltoid tuberosity development | GO:0035993 | 3 | 0.020 | |
| neuromuscular process | GO:0050905 | 99 | 0.020 | |
| blood circulation | GO:0008015 | 195 | 0.020 | |
| respiratory gaseous exchange | GO:0007585 | 43 | 0.020 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.020 | |
| hemostasis | GO:0007599 | 78 | 0.020 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.020 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.020 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.020 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.020 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.019 | |
| neuron projection extension | GO:1990138 | 64 | 0.019 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.019 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.019 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.019 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.019 | |
| wound healing | GO:0042060 | 157 | 0.019 | |
| response to inactivity | GO:0014854 | 4 | 0.019 | |
| prepulse inhibition | GO:0060134 | 10 | 0.019 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.019 | Rat |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.019 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.019 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.019 | |
| muscle tissue development | GO:0060537 | 308 | 0.019 | |
| regulation of protein stability | GO:0031647 | 52 | 0.019 | Human |
| lipid modification | GO:0030258 | 65 | 0.019 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.019 | Human |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.019 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.019 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.019 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.019 | |
| hormone secretion | GO:0046879 | 128 | 0.019 | |
| response to catecholamine | GO:0071869 | 4 | 0.019 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.019 | Human |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.019 | |
| positive regulation of dopamine uptake involved in synaptic transmission | GO:0051586 | 2 | 0.019 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.019 | |
| tetrapyrrole metabolic process | GO:0033013 | 22 | 0.019 | |
| feeding behavior | GO:0007631 | 62 | 0.019 | |
| negative regulation of ion transport | GO:0043271 | 28 | 0.018 | Human |
| neuron maturation | GO:0042551 | 29 | 0.018 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.018 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.018 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.018 | |
| muscle fiber development | GO:0048747 | 76 | 0.018 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.018 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.018 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.018 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.018 | |
| regulation of catecholamine metabolic process | GO:0042069 | 10 | 0.018 | Rat |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.018 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.018 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.018 | |
| regulation of catecholamine uptake involved in synaptic transmission | GO:0051940 | 2 | 0.018 | Human |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.018 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.018 | Human |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.018 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.018 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.018 | |
| activation of transmembrane receptor protein tyrosine kinase activity | GO:0007171 | 3 | 0.018 | |
| stem cell proliferation | GO:0072089 | 117 | 0.017 | |
| sodium ion transport | GO:0006814 | 73 | 0.017 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.017 | Human |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.017 | |
| protein targeting | GO:0006605 | 143 | 0.017 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.017 | |
| regulation of synapse structural plasticity | GO:0051823 | 4 | 0.017 | |
| mitochondrion organization | GO:0007005 | 134 | 0.017 | |
| negative regulation of nucleotide metabolic process | GO:0045980 | 16 | 0.017 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.017 | Human |
| circadian rhythm | GO:0007623 | 114 | 0.017 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.017 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.017 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.017 | |
| response to osmotic stress | GO:0006970 | 21 | 0.017 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.017 | |
| regulation of synaptic vesicle exocytosis | GO:2000300 | 11 | 0.017 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.017 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.017 | |
| myotube differentiation | GO:0014902 | 105 | 0.017 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.017 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.017 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.017 | |
| synaptic vesicle exocytosis | GO:0016079 | 26 | 0.017 | |
| response to alcohol | GO:0097305 | 48 | 0.017 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 30 | 0.017 | |
| regulation of cell migration | GO:0030334 | 219 | 0.016 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.016 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.016 | |
| dna metabolic process | GO:0006259 | 303 | 0.016 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.016 | |
| lipid catabolic process | GO:0016042 | 69 | 0.016 | |
| cell recognition | GO:0008037 | 83 | 0.016 | |
| kidney development | GO:0001822 | 213 | 0.016 | |
| oxidation reduction process | GO:0055114 | 342 | 0.016 | |
| response to peptide | GO:1901652 | 136 | 0.016 | |
| regulation of neuron death | GO:1901214 | 134 | 0.016 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.016 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.016 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.016 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.016 | |
| organelle fusion | GO:0048284 | 28 | 0.016 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.016 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.016 | |
| cellular response to lipid | GO:0071396 | 145 | 0.016 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.016 | |
| cytoskeletal anchoring at plasma membrane | GO:0007016 | 2 | 0.016 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.016 | |
| hexose transport | GO:0008645 | 56 | 0.016 | |
| organelle assembly | GO:0070925 | 177 | 0.016 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.016 | Human |
| muscle adaptation | GO:0043500 | 39 | 0.016 | |
| bone resorption | GO:0045453 | 38 | 0.016 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.015 | Human |
| forebrain cell migration | GO:0021885 | 58 | 0.015 | |
| myosin filament assembly | GO:0031034 | 2 | 0.015 | |
| response to light stimulus | GO:0009416 | 135 | 0.015 | |
| camp metabolic process | GO:0046058 | 40 | 0.015 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.015 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.015 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.015 | |
| response to alkaloid | GO:0043279 | 34 | 0.015 | Rat |
| regulation of synaptic vesicle priming | GO:0010807 | 4 | 0.015 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.015 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.015 | Human |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.015 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.015 | |
| actin filament organization | GO:0007015 | 113 | 0.015 | |
| positive regulation of binding | GO:0051099 | 49 | 0.015 | |
| catecholamine biosynthetic process | GO:0042423 | 11 | 0.015 | |
| toxin transport | GO:1901998 | 38 | 0.015 | |
| response to pain | GO:0048265 | 26 | 0.015 | |
| response to purine containing compound | GO:0014074 | 28 | 0.015 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.015 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.015 | |
| protein maturation | GO:0051604 | 176 | 0.015 | Human |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.015 | |
| tetrapyrrole biosynthetic process | GO:0033014 | 16 | 0.015 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.015 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.015 | |
| multicellular organism growth | GO:0035264 | 161 | 0.015 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.015 | |
| membrane depolarization | GO:0051899 | 64 | 0.015 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.015 | Human |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.015 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.015 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.015 | |
| response to iron ion | GO:0010039 | 4 | 0.015 | Human |
| rhythmic process | GO:0048511 | 174 | 0.015 | |
| protein stabilization | GO:0050821 | 25 | 0.015 | |
| male gamete generation | GO:0048232 | 285 | 0.015 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.014 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.014 | |
| insulin secretion | GO:0030073 | 89 | 0.014 | |
| glial cell development | GO:0021782 | 54 | 0.014 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.014 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.014 | |
| regulation of protein transport | GO:0051223 | 163 | 0.014 | |
